Innate Pharma SA 20-F for FY2021
Innate Pharma SA (IPHA)
20-F
2022-04-04
For: 2021-12-31
View Original
Added on
April 06, 2026
About this 20-F
Innate Pharma SA filed this 20-F on April 4, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 24.7M EUR
- down 64.6% from 69.77M EUR a year earlier
- Net loss
- 52.81M EUR
- compared with a net loss of 63.98M EUR a year earlier
- Diluted EPS
- -0.66 EUR
- compared with -0.81 EUR a year earlier